MARKET

EXAS

EXAS

Exact Sciences Corp
NASDAQ
101.06
-0.07
-0.07%
After Hours: 101.27 +0.21 +0.20% 18:23 12/05 EST
OPEN
101.13
PREV CLOSE
101.13
HIGH
101.26
LOW
101.01
VOLUME
6.63M
TURNOVER
--
52 WEEK HIGH
101.87
52 WEEK LOW
38.81
MARKET CAP
19.18B
P/E (TTM)
-19.0070
1D
5D
1M
3M
1Y
5Y
1D
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?
Benzinga · 1d ago
3 Overrated Stocks That Concern Us
Barchart · 3d ago
Top 2 Health Care Stocks You May Want To Dump This Month
Benzinga · 4d ago
$100 Invested In Exact Sciences 15 Years Ago Would Be Worth This Much Today
Benzinga · 5d ago
Cathie Wood's Ark Invest weekly recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD
Seeking Alpha · 6d ago
Weekly Report: what happened at EXAS last week (1124-1128)?
Weekly Report · 6d ago
Cathie Wood Marks Black Friday with Bitcoin ETF Buy and GitLab Stock Sell-Off
TipRanks · 11/29 14:54
Exact Sciences, Regeneron, Marvell, JFrog, Jazz: Trending by Analysts
TipRanks · 11/29 09:00
More
About EXAS
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Webull offers Exact Sciences Corp stock information, including NASDAQ: EXAS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EXAS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EXAS stock methods without spending real money on the virtual paper trading platform.